These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26974508)

  • 1. Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.
    Thapa P; Li M; Bio M; Rajaputra P; Nkepang G; Sun Y; Woo S; You Y
    J Med Chem; 2016 Apr; 59(7):3204-14. PubMed ID: 26974508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrug.
    Li M; Nguyen L; Subramaniyan B; Bio M; Peer CJ; Kindrick J; Figg WD; Woo S; You Y
    J Control Release; 2019 Aug; 308():86-97. PubMed ID: 31299262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
    Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Singlet oxygen-activatable Paclitaxel prodrugs via intermolecular activation for combined PDT and chemotherapy.
    Bio M; Rahman KMM; Lim I; Rajaputra P; Hurst RE; You Y
    Bioorg Med Chem Lett; 2019 Jun; 29(12):1537-1540. PubMed ID: 30987891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Far-red light activatable, multifunctional prodrug for fluorescence optical imaging and combinational treatment.
    Bio M; Rajaputra P; Nkepang G; You Y
    J Med Chem; 2014 Apr; 57(8):3401-9. PubMed ID: 24694092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
    Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
    Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy.
    Pei Q; Hu X; Zheng X; Liu S; Li Y; Jing X; Xie Z
    ACS Nano; 2018 Feb; 12(2):1630-1641. PubMed ID: 29346736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran-based micelles for combinational chemo-photodynamic therapy of tumors via in vivo chemiluminescence.
    Ding C; Shi Z; Ou M; Li Y; Huang L; Wang W; Huang Q; Li M; Chen C; Zeng X; Chen H; Mei L
    Carbohydr Polym; 2023 Nov; 319():121192. PubMed ID: 37567697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Singlet Oxygen Activatable Prodrugs of Paclitaxel, SN-38, MMC and CA4: Nonmitochondria-Targeted Prodrugs.
    Rahman KMM; Thapa P; Hurst R; Woo S; You Y
    Photochem Photobiol; 2022 Mar; 98(2):389-399. PubMed ID: 34970997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy.
    Hu C; Zhuang W; Yu T; Chen L; Liang Z; Li G; Wang Y
    J Mater Chem B; 2020 Jun; 8(24):5267-5279. PubMed ID: 32441291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen.
    Rajaputra P; Bio M; Nkepang G; Thapa P; Woo S; You Y
    Bioorg Med Chem; 2016 Apr; 24(7):1540-9. PubMed ID: 26928287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor.
    Nkepang G; Bio M; Rajaputra P; Awuah SG; You Y
    Bioconjug Chem; 2014 Dec; 25(12):2175-88. PubMed ID: 25351441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
    Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
    Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy.
    Chen H; Zeng X; Tham HP; Phua SZF; Cheng W; Zeng W; Shi H; Mei L; Zhao Y
    Angew Chem Int Ed Engl; 2019 Jun; 58(23):7641-7646. PubMed ID: 30980463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visible light-activated prodrug system with a novel heavy-atom-free photosensitizer.
    Yang S; Wang L; Loredo A; Wang S; Ada N; Xiao H
    Bioorg Med Chem Lett; 2023 Jul; 91():129365. PubMed ID: 37290494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells.
    Satsangi A; Roy SS; Satsangi RK; Vadlamudi RK; Ong JL
    Mol Pharm; 2014 Jun; 11(6):1906-18. PubMed ID: 24847940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.